video
<乌鸦传媒 class="article_title">
In Indolent Systemic Mastocytosis, Assessing Patient Quality of Life
When is the right time to start treatment for patients with indolent systemic mastocytosis? With the main goal of maintaining or improving quality of life, patients and providers can work together to make that call, explains Sudipto Muhkerjee, MD, PhD, MPH, of Cleveland Clinic. (5:02)
<乌鸦传媒 class="article_title">
Indolent Systemic Mastocytosis and the Impact of Basophil Responsiveness
Abnormal activation of basophils occurs in patients with indolent systemic mastocytosis, with enhanced responsiveness to a chemotactic factor derived from bacteria. Here鈥檚 what this finding鈥攁nd others鈥攎ight imply for future treatments.
video
<乌鸦传媒 class="article_title">
Indolent Systemic Mastocytosis: The Typical Presentation
"We now know that this is a not a very homogeneous group," says Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic. By the time patients are referred to hematology, they often have already completed some level of workup. (2:47)
<乌鸦传媒 class="article_title">
What Drives Hypersensitivity Reactions in Mastocytosis?
An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase levels and stings from certain insects. Here鈥檚 what else the team learned.
<乌鸦传媒 class="article_title">
In Systemic Mastocytosis, What鈥檚 the Impact of Type I Interferon Autoantibodies?
Investigators from the National Institutes of Health recently tackled the challenge of determining whether autoantibodies to type I interferon detected in the serum of patients with systemic mastocytosis are markers of disease severity.
<乌鸦传媒 class="article_title">
Systemic Mastocytosis Screening: Get Standardized
Investigators from Walter Reed Military Medical Center assessed the impact of a standardized screening protocol for systemic mastocytosis.
<乌鸦传媒 class="article_title">
Indolent or Advanced Systemic Mastocytosis? Plasma Protein Profiling May Help
These findings suggest that analyzing a panel of proteins in the blood could help differentiate between indolent and advanced forms of systemic mastocytosis, potentially leading to more precise diagnoses and personalized treatment.
